X Please adjust your browser settings in order to opt out of cookies and review our Privacy Policy for more helpful information


Clinical studies prove the positive impact of low level laser technology in the treatment of acute and *chronic pain, orthopedic conditions, inflammation, sports injuries and wounds. Over 2,000 publications – including more than 100 double-blind studies – have backed the efficacy of low level laser therapy.

B-Cure Laser’s efficacy for the treatment of acute and *chronic pain and wounds has been proven in five double blind clinical trials.
five other clinical trials are in process.

Joint-Related * Chronic Pain(TMJ), Sapienza University in Rome, Italy

Clinical trial of 90 patients (30 B-Cure active Laser, 30 placebo, 30 pain relief medication) affected by Joint-Related Pain (TMJ).
The results:

The double blind clinical trial , involving 90 patients, has shown a significant acute and *chronic pain reduction in the active group vs the B-Cure Placebo Laser . Significance –  p<0.01

Pain reduction of the active group was not different than the drug group.

Published in: Cranio, April 2019

Post Laminectomy, Beneficência of Sao Paulo Hospital, Brazil

The results showed a decrease of temperature, drainage output, acute and *chronic pain relief and accelerated healing in laser group. Significance –  p<0.001 (pain).

The decrease of temperature is an objective measurement ,which further supports the efficacy.

Published in: American Society for Laser Medicine and Surgery 2014. (Submission in process)

Dental Implantations, Health Care Institution of Perm, Russia

The use of original LLLT techniques in prevention and treatment regimens before and after dental implantation significantly reduces the frequency and intensity of the pain symptom. Significance –  p<0.01.The results showed a decrease of temperature, drainage output, acute and *chronic pain relief and accelerated healing in laser group. Significance –  p<0.001 (pain).

Joint-Related Pain (TMJ), University of Parma, Italy

A 50% decrease in acute and *chronic pain level within two weeks, compared to 8% within the control group.
Published in: The “Laser Therapy”, March 2015.

Systematic Literature Review

A systematic literature review published in “Photomedicine and Laser Surgery”, November 2018, supports the outstanding efficacy of B-Cure Laser vs. all medical photomedicine devices for home use worldwide, for the treatment of pain and wound healing.

B-Cure Laser was cited in 4 out of 14 studies! 29% of the patients in the entire literature review studies received the B-Cure Laser therapy treatment.


American College of Physicians’ Guidelines, Low Back Pain

American College of Physicians’ Guidelines include a “strong recommendation” for Low-Level Laser Therapy as a non invasive treatment for acute, subacute & chronic low back pain.
(April 2017).

The LANCET, Neck Pain

We show that LLLT reduces pain immediately after treatment in acute neck pain and up to 22 weeks after completion of treatment in patients with chronic neck pain”.
(December 2009)

MASCC’ Guidelines, Oral Mucositis

International guidelines recommend the “use of low level laser therapy for treatment of Oral Mucositis“.
(November 2018).


* B Cure/Erika Carmel Ltd. is not a medical organization and any information displayed is not intended as diagnosis or medical advice. The medical information is provided for general information, education use and as an overview of the intended use of our device, and should not be regarded as medical advice, diagnosis or substitute for professional advice. The results from using our devices may vary between different individuals due to differences in medical history, genetics, age, gender and other factors. Accordingly, prior to taking any actions we encourage you to consult an appropriate medical professional and carefully review the indications for use available at:
Further, you should always consult your physician or a qualified health care practitioner before using our devices. The use of the device and reliance on the information provided herein is at your own risk.